beauverolides has been researched along with Arteriosclerosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishibashi, S; Namatame, I; Omura, S; Tomoda, H | 1 |
| Neeper, S | 1 |
| Holzgrabe, U | 1 |
| Doi, T; Tomoda, H | 1 |
1 review(s) available for beauverolides and Arteriosclerosis
| Article | Year |
|---|---|
Discovery and combinatorial synthesis of fungal metabolites beauveriolides, novel antiatherosclerotic agents.
Topics: Animals; Arteriosclerosis; Combinatorial Chemistry Techniques; Depsipeptides; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Lipids; Macrophages; Mice; Stereoisomerism; Sterol O-Acyltransferase | 2008 |
3 other study(ies) available for beauverolides and Arteriosclerosis
| Article | Year |
|---|---|
Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages.
Topics: Administration, Oral; Animals; Apolipoproteins E; Arteriosclerosis; Cholesterol Esters; Depsipeptides; Enzyme Inhibitors; Female; Hypocreales; Hypolipidemic Agents; In Vitro Techniques; Lipid Metabolism; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Knockout; Peptides, Cyclic; Receptors, LDL; Sterol O-Acyltransferase | 2004 |
Lipid-control allies.
Topics: Animals; Arteriosclerosis; Depsipeptides; Enzyme Inhibitors; Humans; Hypolipidemic Agents; Peptides, Cyclic; Sterol O-Acyltransferase | 2004 |
[A fungal substance against arteriosclerosis].
Topics: Animals; Arteriosclerosis; Depsipeptides; Fungi; Mice; Mice, Knockout; Receptors, LDL | 2004 |